20 results about "Artemisia capillaris" patented technology

This invention belongs to the field of traditional Chinese medicine treatment, specifically relating to an anti-cold and detoxifying capsule pharmaceutical composition, its preparation method, and its application. The composition comprises the following components in parts by weight: 25-35 parts Angelica dahurica, 40-50 parts Scutellaria baicalensis, 2-5 parts flavonoids, 0.5-2 parts Imperatorin, 1-5 parts Artemisia capillaris, 1-5 parts phloroglucinol compounds, and 0.1-0.5 parts organic acids. The component-based composition provided by this invention has a good effect in preventing and treating wind-heat colds, and the components exhibit good synergistic effects.

This invention relates to a traditional Chinese medicine combination for treating intrahepatic cholestasis, which is made from the following raw materials in parts by weight: Artemisia capillaris and Glycyrrhiza uralensis 5:1 and 3:1. This invention also provides the preparation of the above-mentioned medicine and its use in treating intrahepatic cholestasis. Its advantages are: the traditional Chinese medicine composition of this invention (Artemisia capillaris and Glycyrrhiza uralensis decoction) has a significant ameliorative effect on intrahepatic cholestasis (non-obstructive type) induced by a 1% CA-containing diet in mice. Artemisia capillaris and Glycyrrhiza uralensis decoction can alleviate weight loss in mice and improve liver necrosis; significantly reduce serum ALT and ALP levels in mice; reduce the content of total bile acids in the liver and decrease the proportion of toxic bile acid taurine deoxycholic acid (TDCA) in the bile acid pool; upregulate liver BSEP protein expression to promote bile acid efflux; and downregulate liver NLRP3 protein expression to alleviate liver necrosis.

This invention relates to the field of external moxibustion devices in traditional Chinese medicine, and in particular to a moxa stick for clearing dampness using the thunder-fire method, and its preparation method. The moxa stick comprises moxa wool, compound Chinese herbal powder, and moxa leaf paper; the compound Chinese herbal powder includes principal, assistant, adjuvant, and guiding herbs; the principal herbs include Evodia rutaecarpa, Cinnamomum cassia, and Ligusticum chuanxiong; the assistant herbs include stir-fried Atractylodes lancea, Poria cocos, Polyporus umbellatus, Alisma plantago-aquatica, stir-fried Atractylodes macrocephala, Astragalus membranaceus, and Amomum villosum; the adjuvant herbs include stir-fried Phellodendron chinense, Sophora flavescens, Artemisia capillaris, Gardenia jasminoides, Akebia quinata, Pinellia ternata, Centella asiatica, and Rosa laevigata root; the guiding herbs include Angelica dahurica, Pogostemon cablin, Angelica sinensis, Paeonia lactiflora, Glycyrrhiza uralensis, and Nelumbo nucifera leaf. This invention, guided by compound formulation theory, material innovation, process optimization, and packaging design, provides a thunder-fire moxa stick with strong targeted dampness-clearing properties, stable combustion performance, safety, portability, and controllable quality, showing promising application prospects.

This invention belongs to the field of pharmaceutical technology, specifically relating to the application of a composition in the preparation of a drug for treating diabetic wounds. The composition comprises the following components: *Artemisia capillaris* exosomes, epi-suberol, and 3-hydroxymorinogenone, with a mass ratio of 1:0.1-0.25:0.02-0.05. In this composition, *Artemisia capillaris* exosomes can penetrate the thickened inflammatory exudate layer and glycosylated extracellular matrix of diabetic wounds, reshaping the wound's immune repair microenvironment, promoting fibroblast activation and proliferation, regulating collagen synthesis and deposition, and reducing scar hyperplasia. 3-hydroxymorinogenone can increase vascular endothelial growth factor, promote angiogenesis, and thus promote the repair and healing of diabetic wounds. The synergistic effect of *Artemisia capillaris* exosomes, epi-suberol, and 3-hydroxymorinogenone in this composition significantly shortens the healing cycle of difficult-to-heal diabetic wounds and improves the quality of wound healing.

This invention discloses a low-bitterness liver-protecting and qi-tonifying compound tea and its preparation method, belonging to the field of substitute tea technology. The compound tea, by weight, is composed of 100 parts tea leaves, 7-9 parts Artemisia capillaris extract, 4-6 parts ginseng extract, 0.8-1.2 parts Lycium barbarum extract, 0.5-0.8 parts roasted malt extract, and 0.7-1.0 parts β-cyclodextrin. The preparation process employs low-temperature ultrasonic extraction, membrane separation for bitterness removal, β-cyclodextrin encapsulation, and vacuum spray adsorption to load the effective components into the tea leaves, followed by low-temperature drying to obtain the finished product. The compound tea prepared by this invention has no obvious medicinal or fishy taste, a mild and palatable flavor, and possesses conditioning effects such as liver protection, qi tonification, vision improvement, and stomach nourishment. It exhibits high dissolution rate and good stability of the effective components, making it suitable for long-term daily tea consumption. It solves the problems of strong bitterness and poor palatability in traditional health teas and has good application prospects.

This invention discloses the contents of a Tibetan Artemisia capillaris capsule, which is prepared from the following raw and excipient materials in weight percentages: 55%–59% filler, 3%–6% flow aid, and the remainder being Tibetan Artemisia capillaris extract; the Tibetan Artemisia capillaris extract is an alcoholic extract of Tibetan Artemisia capillaris. The Tibetan Artemisia capillaris granules of this invention not only meet the quality requirements of the pharmacopoeia but also have low cost, making them suitable for large-scale industrial production.

The present application relates to the technical field of oral liquid, in particular to a kind of oral liquid for preventing and treating perinatal energy metabolism disorder disease of dairy cow and preparation method thereof, it is characterized in that, the oral liquid for preventing and treating perinatal energy metabolism disorder disease of dairy cow is made of the following components, by weight parts: artemisia capillaris 200~300 parts, gardenia 150~200 parts, bupleurum 100~150 parts, polygonatum 50~100 parts, radix paeoniae alba 50~100 parts, liquorice 10~50 parts, nicotinic acid 1~10 parts, propylene glycol 200~300 parts, fructose diphosphate sodium 1~10 parts, pure water 200~400 parts.The oral liquid for preventing and treating perinatal energy metabolism disorder disease of dairy cow can prevent and treat ketosis, fatty liver and liver damage at the same time, comprehensively improve the constitution of new cow, improve immunity, improve physical indicators and reproductive performance, increase economic benefits.

This invention relates to a choleretic traditional Chinese medicine composition, its preparation method, and its application, belonging to the field of traditional Chinese medicine preparation technology. The microcapsules prepared from this choleretic traditional Chinese medicine composition consist of a core and a coating. The core contains a traditional Chinese medicine extract, pregelatinized starch, sodium alginate, and croscarmellose sodium. The coating contains hydroxypropyl cellulose and hydroxypropyl methylcellulose E5, PEG4000, and talc. The traditional Chinese medicine extract is made from Artemisia capillaris, Lysimachia christinae, Rheum palmatum, Scutellaria baicalensis, Taraxacum mongolicum, Forsythia suspensa, Curcuma longa, Curcuma longa, Bupleurum chinense, Citrus aurantium, and Aucklandia lappa. This choleretic traditional Chinese medicine composition has the effects of promoting bile flow and expelling gallstones, detoxifying and reducing swelling, with a stable drug release rate, definite efficacy, and few toxic side effects. It can be used for the prevention and / or treatment of acute and chronic gallstones and / or cholecystitis.

This invention discloses a traditional Chinese medicine composition for treating liver fibrosis with damp-heat toxicity, comprising the following raw materials in parts by weight: 20-30 parts of processed turtle shell, 18-25 parts of Oldenlandia diffusa, 11-15 parts of Curcuma zedoaria, 20-30 parts of processed Salvia miltiorrhiza (wine-processed), 14-20 parts of Scutellaria barbata, 11-15 parts of Epimedium, 10-15 parts of Artemisia capillaris, 14-20 parts of Sedum sarmentosum, 7-10 parts of Bupleurum chinense, 7-10 parts of Curcuma longa, 6-8 parts of dried ginger, 11-15 parts of stir-fried Atractylodes macrocephala, 18-25 parts of Astragalus membranaceus, 7-10 parts of Prunus persica, 8-12 parts of Schisandra chinensis, 4-6 parts of Panax notoginseng (powder), 14-20 parts of Poria cocos, and 3-5 parts of Cinnamomum cassia. This traditional Chinese medicine composition is developed based on the principles of TCM syndrome differentiation and treatment for liver fibrosis with damp-heat toxicity, and has the expected therapeutic effect on this condition.

This invention relates to a decoction process and equipment for treating non-alcoholic fatty liver disease (NAFLD). The raw materials of the decoction, by weight, are: 15 parts Artemisia capillaris, 10 parts Gardenia jasminoides, 10 parts Crataegus pinnatifida, 10 parts Bupleurum chinense, 15 parts stir-fried Paeonia lactiflora, 10 parts Citrus aurantium, 5 parts Glycyrrhiza uralensis, 10 parts Nelumbo nucifera, 15 parts Cassia tora, 10 parts Gynostemma pentaphyllum, 30 parts Benincasa hispida peel, 15 parts Salvia miltiorrhiza, and 9 parts Atractylodes lancea. The equipment includes a decoction container and a container lid. A connecting column is provided on the lower surface of the container lid. A first medicine-carrying mesh tray is fixed at the bottom of the connecting column. A second medicine-carrying mesh tray is longitudinally hinged to each side of the first medicine-carrying mesh tray. A rotating sleeve is provided on the upper part of the connecting column. The rotating sleeve is connected to the outer side of the second medicine-carrying mesh tray through multiple stainless steel ropes. This invention transforms the traditional wisdom of batch decoction in traditional Chinese medicine into a standard process that can be executed by modern automated equipment, and provides a standardized decoction solution for the treatment of NAFLD with traditional Chinese medicine that is more effective, safer to use, and easier to operate.

This invention discloses a traditional Chinese medicine composition for improving dark circles under the eyes and its application, belonging to the field of traditional Chinese medicine technology. Targeting the core pathogenesis of liver and kidney yin deficiency and qi stagnation and blood stasis, this invention, based on the theory of "principal, assistant, adjuvant, and guide" in traditional Chinese medicine formulation, uses *Artemisia capillaris* as the principal herb, peach kernel, *Corydalis yanhusuo*, and *Viola yedoensis* as assistant herbs, *Caesalpinia sappan*, *Notopterygium incisum*, *Kochia scoparia*, and turmeric as adjuvant herbs, and *Clematis chinensis* and *Lycopodium clavatum* as guide herbs to prepare a traditional Chinese medicine composition for improving dark circles under the eyes. This traditional Chinese medicine composition has the effects of promoting blood circulation and removing blood stasis, regulating qi and unblocking collaterals, clearing heat and cooling blood, reducing swelling and promoting diuresis. It can effectively improve the obstruction of collaterals around the eyes, tissue malnutrition, and water retention, thereby achieving the effect of lightening dark circles and improving the overall condition of the eye area.

This invention belongs to the field of veterinary biological products technology, specifically relating to a traditional Chinese medicine composition for improving plasma titer and protecting the liver in tetanus-immunized horses, and its application. The composition consists of the following herbs in parts by weight: Angelica sinensis 20-30 parts, Paeonia lactiflora 20-30 parts, Bupleurum chinense 15-20 parts, Atractylodes macrocephala 25-35 parts, Poria cocos 20-30 parts, and Artemisia capillaris 30-40 parts. Experiments show that the composition of this invention can increase the average IgG titer of culled horses with low titers (initial IgG titer 800-1200 IU / mL) by more than 250 IU / mL after an 18-week immunization cycle, far exceeding the predetermined target of 200 IU / mL. Simultaneously, it significantly increases the immunization pass rate (≥1300 IU / mL) of newly immunized horses from 73.3% in the control group to 93.3%, an absolute increase of 20 percentage points. Furthermore, the area under the IgG titer-time curve (AUC) is 1.3 times higher than that of the control group, indicating a significant increase in the cumulative antibody production throughout the immunization cycle. This invention improves the plasma titer of horses while also protecting the liver, and has good application prospects.

This invention belongs to the field of traditional Chinese medicine compositions and relates to a composition for treating non-alcoholic fatty liver disease that clears the liver, invigorates the spleen, and removes blood stasis. The composition is composed of the following raw materials by weight: Artemisia capillaris 10-25g, Tea tree root 20-30g, Aristolochia debilis 20-30g, Earthworm 5-15g, Sophora japonica flower 5-15g, Bamboo shavings 5-10g, Nardostachys chinensis 3-6g, Lotus seed heart 3-6g, Ganoderma lucidum 6-12g, Prickly pear 10-15g, and Prepared licorice root 5-15g. This combination therapy, based on the concepts of "stasis, phlegm, stagnation, and deficiency" and the theory of inter-organ communication, treats non-alcoholic fatty liver disease by clearing the liver and relieving stagnation, strengthening the spleen and removing dampness, and promoting bowel movement. It also includes drugs that directly enter the liver meridian to invigorate blood circulation, remove blood stasis, and protect the body's vital energy, strengthen the spleen, and replenish deficiency. This combination of strengthening the spleen and clearing the liver, and invigorating blood circulation and removing blood stasis has a good therapeutic effect, with an effective rate of up to 97.83%. It is especially suitable for patients with non-alcoholic fatty liver disease of the phlegm-stasis type.

This invention discloses a traditional Chinese medicine ointment containing antibacterial, blood-activating, and tissue-regenerating components and its preparation method. It is prepared from the following raw materials in the indicated weight ratios: Coptis chinensis 8-12 parts, Phellodendron chinense 4-8 parts, Scutellaria baicalensis 4-8 parts, Polygonum cuspidatum 8-12 parts, Lonicera japonica 10-20 parts, Pseudolarix amabilis bark 8-12 parts, Lithospermum erythrorhizon 8-12 parts, Rheum palmatum (processed with wine) 7-11 parts, Sanguisorba officinalis 8-12 parts, Borneol 2-4 parts, Scolopendra subspinipes powder 1-3 parts, Salvia miltiorrhiza 10-2 parts. 0 parts, Angelica sinensis 10-20 parts, Spatholobus suberectus 10-30 parts, Dragon's blood 6-10 parts, Artemisia capillaris 8-12 parts, Frankincense 4-8 parts, Myrrh 4-8 parts, Rhubarb (processed with wine) 7-11 parts, Bletilla striata 8-12 parts, Catechu 8-12 parts, Calcined gypsum 10-20 parts, Lithospermum erythrorhizon 8-12 parts, Sanguisorba officinalis 8-12 parts, Centella asiatica 10-20 parts, Astragalus membranaceus 30-50 parts, Angelica dahurica 8-12 parts, Borneol 2-4 parts. This herbal ointment of the present invention achieves the effects of promoting the healing of chronic, refractory wounds, shortening healing time, and reducing scar formation.

This invention provides a traditional Chinese medicine preparation for treating Hashimoto's thyroiditis and its preparation method, belonging to the field of traditional Chinese medicine pharmaceutical technology. The preparation is made from Curcuma zedoaria, oyster shell, Eclipta prostrata, Ligustrum lucidum, Sargassum, processed Aconitum carmichaelii, Cremastra appendiculata, Duchesnea indica, Hedyotis diffusa, Artemisia capillaris, Oroxylum indicum, and cinnamon. The formula is meticulously formulated, closely addressing the core pathogenesis of Hashimoto's thyroiditis: "phlegm and blood stasis, spleen and kidney deficiency, and nutritional imbalance." It focuses on "eliminating masses and dispersing nodules, promoting qi and blood circulation," fully embodying the TCM diagnostic and treatment approach of "differentiating syndromes and treating accordingly, addressing both the root cause and symptoms." This invention's preparation has a good therapeutic effect on Hashimoto's thyroiditis, effectively improving thyroid autoimmune disorders, regulating thyroid function, and alleviating symptoms of local thyroid inflammation in experimentally induced Hashimoto's thyroiditis rats. Further clinical observation studies have found that this preparation significantly improves the overall effective rate of clinical treatment for Hashimoto's thyroiditis patients, providing a new approach to the treatment of this condition.

This invention belongs to the field of biomedical technology, specifically relating to a traditional Chinese medicine preparation for protecting the liver of ducks and geese and its preparation method. This preparation is made from the following raw materials in parts by weight: Bupleurum chinense 5-15 parts, Artemisia capillaris 10-25 parts, Sedum sarmentosum 10-20 parts, Schisandra chinensis 5-12 parts, Astragalus membranaceus 8-20 parts, Poria cocos 6-18 parts, Atractylodes macrocephala 5-15 parts, Salvia miltiorrhiza 5-12 parts, Taraxacum mongolicum 10-25 parts, Alisma plantago-aquatica 5-15 parts, Glycyrrhiza uralensis 3-10 parts, Ivy 3-10 parts, and Mealworm pupae 2-8 parts. This invention introduces Ivy and Mealworm pupae into the formula for protecting the liver of ducks and geese, enhancing the liver-protecting effect. Simultaneously, it pioneers a "liver-intestine co-regulation" dual-target system, filling the gap in existing technologies that neglect the intestinal-liver axis linkage mechanism, thus improving the repair effect on intestinal-liver axis damage.

The present application relates to the field of scalp water, in particular to a scalp water with moisturizing, soothing and firming effects, and a preparation method and application thereof. The present application selects active ingredients such as black truffle extract, ginkgo kuzhuang extract, artemisia capillaris extract and yellow flower nine-wheel grass extract, and raw materials with moisturizing, soothing and firming effects such as moisturizing agent, tripeptide-1, hamamelis virginiana extract, dipotassium glycyrrhizate and bisabolol, so that the scalp water has moisturizing, soothing and firming properties. At the same time, the present application optimizes the selection of raw materials and improves the process and collocation of extracts, further improving the performance of firming the scalp and soothing the scalp.

The application discloses a compound for eye disease repair and a preparation method of the compound by aging extraction, which is synthesized by extracting effective components of Senecio scandens Buch, astaxanthin, Artemisia capillaris Thunb, Gardenia, Ceti, Cassia seed, and has good therapeutic effect on eye diseases such as myopia, pseudomyopia, cataract, glaucoma, chloasma and the like. By taking the extract, intraocular pressure, optic nerve and intraocular pressure tube are gradually improved, so that the eye axis refraction is basically recovered, and the purpose of basic cure is achieved. The extract is obtained by supercritical extraction of pure plants and traditional Chinese medicines, and the compound Tianmocai compound of Senecio scandens Buch is obtained by using three reaction kettles to induce aging technology, the compound is safe and has no side effect, and is an innovative modern new Chinese medicine technical product.

This invention relates to the field of traditional Chinese medicine composition technology, and particularly to a traditional Chinese medicine composition for treating damp-heat type vaginitis or damp-heat type HPV and its preparation method. The traditional Chinese medicine composition for treating damp-heat type vaginitis or damp-heat type HPV of this invention has the advantages of rapid efficacy and few side effects. The principal herbs are Gentiana scabra, Artemisia capillaris, and Prunella vulgaris, which are cold in nature and clear excess heat in the liver and gallbladder, and clear damp-heat in the lower burner; the assistant herb is Scutellaria baicalensis, which is bitter and cold and clears heat, assisting Gentiana scabra and Prunella vulgaris in clearing heat and detoxifying; the adjuvant herbs are Rehmannia glutinosa, Hedyotis diffusa, and Forsythia suspensa, which have the effects of clearing heat and detoxifying; the guiding herbs are Plantago asiatica and Salvia miltiorrhiza. Plantago asiatica promotes diuresis and eliminates dampness, guides heat downwards, and allows damp-heat to be expelled through urination; Salvia miltiorrhiza, the guiding herb, enters the heart and liver meridians, is bitter and slightly cold in taste, and has blood-activating effects. Modern medical research shows that it has the effect of inhibiting the release of inflammatory factors and reducing tissue inflammatory reactions. This invention, through the combination of its components, achieves significant therapeutic effects on damp-heat type vaginitis and damp-heat type HPV.

The application discloses a plateau herbal compound mosquito-repelling Tibetan incense and a preparation method thereof, which is composed of the following raw materials in parts by weight: artemisia capillaris 15-25 parts, Tibetan saussurea 8-12 parts, natural borneol 3-5 parts, benzoin 4-6 parts, rhododendron anthopogon 5-8 parts, tibetan wormwood 4-6 parts, impatiens walleriana 3-5 parts, meconopsis tangutica 3-5 parts, cnidium 3-5 parts, prunus buergeriana 2-4 parts, syzygium aromaticum 2-4 parts, zanthoxylum 4-6 parts, sandalwood 4-6 parts, sabina tibetica 10-15 parts, elm bark 5-8 parts, white willow 3-5 parts, brown sugar 2-3 parts, and agarwood 1-3 parts. The plateau herbal compound mosquito-repelling Tibetan incense is safe and non-toxic, has high and long-lasting mosquito-repelling efficiency, has the functions of soothing nerves and purifying air, has a green and mass-productive process, has ecological value, and is suitable for plain areas, high-mosquito-environment areas and sensitive people.